News
This five-year analysis of the C-144-01 trial represents unprecedented durability and duration of follow-up in advanced melanoma patients previously treated with anti-PD-1 and targeted therapy, where ...
The process is called extracellular respiration, which mimics how batteries discharge electric current -- allowing bacteria ...
New Delhi: India is poised to see a massive surge in demand for Artificial Intelligence (AI) professionals, with projections ...
Scientists map 193 cannabis genomes, uncovering hidden diversity and new possibilities for agriculture, medicine, and ...
Freenome, a biotechnology company pioneering an early cancer detection platform, today announced the publication of detailed results from the pivotal PREEMPT CRC study in JAMA.1 The publication ...
Amgen today announced new interim results from the global Phase 3 DeLLphi-304 trial showing IMDELLTRA® (tarlatamab-dlle) reduced the risk of death by 40% and significantly extended median overall ...
The fashion and textile industries are also exploring mushroom-derived leather alternatives. Mycelium-based leather offers a ...
The journal aims to fill a gap in the ACS journal portfolio by covering research areas like molecular nutrition and clinical nutrition ...
The data showed a surprisingly compelling overall survival (OS) benefit. TheBraftovi combination regimen received Food and ...
A chyut Adhikari has spent his career exploring how to make fresh food safer without the use of synthetic chemicals. An ...
Three BriaCell posters and one publish-only abstract highlight robust clinical data from Bria-IMT™ and Bria-OTS™ studies in ...
Explore how Shilajit’s unique phytocomplex and fulvic acid are being evaluated for their roles in cognitive health, metabolic support, and anti-aging, amid growing demand and ongoing safety debates.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results